January 2012 - Sandwell & West Birmingham Hospitals

SWBTB (1/12) 269(a)
Trust Board Public Session January 2012
Implications of the Innovation, Health and Wealth Report
1.0 Introduction
Published by the Department of Health in December 2011, the Innovation, Health
and Wealth Report outlines the NHS Chief Executive’s review of how adoption and
diffusion of innovation could be accelerated across the NHS. This review forms
part of the wider UK strategy for Health Innovation and Life Sciences led by the
Prime Minister’s delivery unit.
As part of the proposed approach, the report outlines a number of key actions that
are planned to come into effect that will be expected to be delivered by NHS
Trusts and Commissioning Bodies, performance against which will be monitored
by the NHS Commissioning Board.
This report outlines a summary of those actions required for consideration by the
Board.
2.0 Summary of Key Actions
2.1 Reducing Variation and Strengthening Compliance
The report proposes that further work needs to take place in order to ensure
adherence to the recommendations proposed by NICE both in its current and
future role. This will include:
A. Introduction of a NICE compliance regime to reduce variation and drive up
compliance with NICE technology appraisals. This will effectively mean that
there should be no local barriers to accessing technologies recommended
in NICE appraisals, beyond a clinical decision relating to an individual
patient.
B. It will be required that all NICE technology appraisal recommendations are
automatically incorporated into relevant local NHS formularies.
2.2 Metrics and Information
The report outlines a need to identify and measure individual organisational
performance in adopting innovation. To support this, key actions include:
A. The NHS Commissioning Board will develop and publish a straightforward
innovation scorecard designed to track adoption of NICE technology
appraisals, which will be required by all Trusts at a local level.
Page 1 of 5